Campbell & CO Investment Adviser LLC Vericel Corp Transaction History

Campbell & CO Investment Adviser LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$30.85 - $37.09 $247,540 - $297,610	8,024 New	8,024 $285,000
Q2 2022 Aug 09, 2022	BUY	$22.88 - $39.45 $430,990 - $743,119	18,837 New	18,837 $474,000
Q2 2021 Aug 11, 2021	SELL	$47.2 - $67.81 $283,200 - $406,860	-6,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$30.93 - $59.48 $64,953 - $124,908	-2,100 Reduced 25.93%	6,000 $333,000
Q4 2020 Feb 09, 2021	BUY	$18.53 - $31.5 $150,093 - $255,150	8,100 New	8,100 $250,000
Q1 2020 Apr 29, 2020	SELL	$7.25 - $19.22 $238,481 - $632,222	-32,894 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$13.77 - $19.2 $452,950 - $631,564	32,894 New	32,894 $572,000

279

48.7M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.76B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.